Share Prices & Company Research

Market News

01 Oct 2020 | 07:24

Smith & Nephew revenue decline slows as markets pick up

(Sharecast News) - Medical technology company Smith & Nephew updated the market on its recent trading on Thursday, reporting that it expects a third quarter underlying revenue decline of around 4%. The FTSE 100 company said all three of its franchises showed "significant" recovery following an overall underlying revenue decline of 29.3% for the second quarter.

It said the improvement was strongest in its orthopaedics franchise, as global levels of elective surgery continued to recover.

Monthly group growth rates were described as "broadly stable" through the quarter, with some seasonality and monthly variation across both franchises and regions, reflecting the continuing impact of the Covid-19 pandemic.

"Throughout the year, we have been serving our customers, maintaining research and development, continuing with acquisitions, and launching new products, while managing our cost base and protecting employees and their jobs," the board said in its statement.

Smith & Nephew said further detail of the quarter, including franchise and regional sales performance, would be provided with its third quarter trading report on 29 October.

At 0846 BST, shares in Smith & Nephew were up 2.08% at 1,548p.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 15th January 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.